“The preventive effect of emodin was blocked by pre-treatment with a phosphatidylinositol-3-kinase (PI3K) pathway inhibitor LY294002 or an estrogen receptor (ER) specific antagonist ICI182780 , but not by pre-treatment with an extracellular signal-related kinases (ERK) inhibitor U0126.”